Israeli company reveals nasal spray of psychedelic mushrooms
Madrigal Mental Care says the spray treats post-traumatic stress disorder, anxiety and other mental challenges. Some experts believe magic mushrooms have health benefits, though they come with risks.
Israel’s Madrigal Mental Care announced today a nasal spray featuring psychedelic mushrooms.
The Beersheba-based biopharmaceutical company’s spray emits nanoparticles that encapsulate psilocybin, which is found in psychedelic mushrooms ("shrooms"). The spray also contains the pain drug ketamine, the recreational drug MDMA (molly or ecstasy) and other substances. The spray is designed to treat post-traumatic stress disorder (PTSD), anxiety, depression and other issues, Madrigal said in a press release.
“Due to their powerful effect on the human brain, it is imperative to be able to deliver these drugs in a safe manner and in precise doses,” said Ben Gurion University professor Amnon Sintov, who developed the product.
Madrigal announced the spray ahead of the Biomed Israel Conference and Exhibition in Tel Aviv, which begins tomorrow.
